evidencegaps
Primary study · included by 1 review

Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients.

Yadav 2020 · Yadav Madhav Prasad, Ballal Sanjana, Sahoo Ranjit Kumar, et al. · Theranostics · 2020

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.
Non-Cochrane · intervention · 2026 · cited as Yadav 2020 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.